In meta-analysis by Yi Liu, et al. on colorectal cancer reported that TGF-β1 polymorphisms including +915 G>C (GG) and TGF-β1 −509 C>T (TT) were not associated with risk of colorectal adenoma and colorectal cancer (CRC). This evidence concerns the gene TGFB1 and colorectal adenoma.